FDA Approves Abbott's Next-Generation MitraClip Device

 

July 12, 2018—Abbott Vascular announced approval from the FDA for the company's third-generation MitraClip transcatheter heart valve repair device. Abbott received European CE Mark approval for the device earlier this year.

According to the company, the next-generation MitraClip system provides advanced steering, navigation, and positioning capabilities for the clip, making it easier to use in difficult anatomies. The enhanced system is designed to allow for more precise placement during deployment, resulting in more predictable procedures, and additionally offers a second clip size with longer arms that expands the reach of the clip-based device. The additional clip size is designed for mitral valve repair treatment of patients with more complex anatomies.

Professor Francesco Maisano, MD, commented in Abbott's announcement, "Physicians rely on MitraClip as an alternative to surgery for patients who aren't surgical candidates and may need treatment to relieve their symptoms or to survive. The enhanced MitraClip design allows for even more precise navigation, accuracy, and stability during valve repairs, which may be important when treating people with more complex or advanced valve disease."

The company advised that it recently began enrollment in the EXPAND clinical study, which is a prospective study evaluating the safety and performance of the new MitraClip system in a contemporary real-world setting.

EXPAND Lead Investigator Saibal Kar, MD, who is Director of Interventional Cardiac Research at the Smidt Heart Institute at Cedars-Sinai in Los Angeles, California, treated the first patient enrolled in the trial. EXPAND will enroll approximately 1,000 patients in more than 50 centers across the United States and Europe. Interim results from the study are expected later this year, stated the company.

 

Contact Info

For advertising rates and opportunities, contact:
Craig McChesney
484-581-1816
cmcchesney@bmctoday.com

Stephen Hoerst
484-581-1817
shoerst@bmctoday.com

Charles Philip
484-581-1873
cphillip@bmctoday.com

About Cardiac Interventions Today

Cardiac Interventions Today (ISSN 2572-5955 print and ISSN 2572-5963 online) is a publication dedicated to providing comprehensive coverage of the latest developments in technology, techniques, clinical studies, and regulatory and reimbursement issues in the field of coronary and cardiac interventions. Cardiac Interventions Today premiered in March 2007 and each edition contains a variety of topics in a flexible format, including articles covering various perspectives on current clinical topics, in-depth interviews with expert physicians, overviews of available technologies, industry news, and insights into the issues affecting today's interventional cardiology practices.